Publications by authors named "Ian D Pavord"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

404

Total Likes

29

Extended Reach

56,374

Social Features

23
T
Treatable traits in the NOVELTY study.
Alvar Agustí, Eleni Rapsomaniki, Richard Beasley, Rod Hughes, Hana Müllerová, Alberto Papi, Ian D Pavord, Maarten van den Berge, Rosa Faner,

Respirology· November 2022

Videos about Article: user user

2 21 2 2

View All Article and Social Media Activity
N
Normal FEV without Reversibility in Asthma Trials: A Placebo Patient-Level Meta-Analysis.
Simon Couillard, Samuel Mailhot-Larouche, Fleur L Meulmeester, Guy Brusselle, Philippe Lachapelle, Ian D Pavord

Am J Respir Crit Care Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Misconceptions of Traits to Predict Response to Inhaled Corticosteroid and Bronchodilator Therapies in Asthma: A Narrative Review.
Guy Brusselle, Jodie Crawford, Peter G Gibson, David Leather, Alison Moore, Ian D Pavord

Pulm Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acceptability and feasibility of biomarkers of airway eosinophilic inflammation for the management of preschool wheeze: a qualitative study.
Andreas Perikleous, Grace Lewis, Sarah-Jane Bowen, Ian Douglas Pavord, Louise Fleming

Arch Dis Child· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Risk-Benefit Balance of Oral Corticosteroid Treatment for Asthma Attacks: A Discrete Choice Experiment of Patients and Healthcare Professionals in the UK and New Zealand.
Imran Howell, Jonathan Noble, Aleksandra Howell, Caitlin Morgan, Jennifer Logan, Ian D Pavord

Respirology· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reframing remission in severe asthma: a conceptual framework for distinguishing disease activity versus damage.
Celeste Porsbjerg, Hitasha Rupani, John D Brannan, Shigeharu Ueki, Martijn C Nawijn, Ian D Pavord

Lancet Respir Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological Therapies in Chronic Obstructive Pulmonary Disease: New Directions in Personalised Respiratory Medicine.
Benjamin Mappin-Kasirer, Ian D Pavord

BioDrugs· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fractional exhaled nitric oxide and the response to prednisolone for asthma attacks in patients treated with anti-IL5/5Rα therapy: a prospective observational study.
Imran Howell, Mahdi Mahdi, Hafiz R Mahmood, Laura Bermejo-Sanchez, Catherine Borg, Ian D Pavord

Eur Respir J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient Early Blood Eosinophil Increases Do Not Affect Dupilumab's Long-Term Efficacy in Patients with Moderate-to-Severe Asthma.
Ian D Pavord, Njira L Lugogo, Mario Castro, Alberto Papi, Arnaud Bourdin

J Allergy Clin Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of airway inflammation demonstrates a mechanism for T2-biologic failure in asthma.
P Jane McDowell, Adnan Azim, John Busby, Sarah Diver, Freda Yang, Ian D Pavord

J Allergy Clin Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphoma in patients with asthma treated with dupilumab: much ado about nothing?
Timothy J Davies, Ian D Pavord

Eur Respir J· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab efficacy in patients with type 2 asthma and early Feno level reductions.
Ian D Pavord, Michael E Wechsler, William W Busse, Christian Domingo, Changming Xia

J Allergy Clin Immunol Glob· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease Modification in Severe Asthma-Are We There Yet?
Ian D Pavord, Stephanie Christenson, Reynold A Panettieri

J Allergy Clin Immunol Pract· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker Profiles in Severe Asthma.
Ian D Pavord, Michael E Wechsler

J Allergy Clin Immunol Pract· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability of Fractional Exhaled Nitric Oxide and Its Relationship With Exacerbation in Patients Aged 6 Years or Older With Uncontrolled, Moderate-to-Severe Asthma.
William W Busse, Ian D Pavord, Michael E Wechsler, Ignacio J Davila, Arman Altincatal

Chest· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatable Trait Guided Asthma Management: A Feasibility Study.
James Fingleton, Rob McLachlan, Jenny Sparks, Richard Beasley, Alvar Agustí, Ian D Pavord

Respirology· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials.
Fleur L Meulmeester, Samuel Mailhot-Larouche, Carlos Celis-Preciado, Samuel Lemaire-Paquette, Sanjay Ramakrishnan, Ian D Pavord

Lancet Respir Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tezepelumab can Restore Normal Lung Function in Patients with Severe, Uncontrolled Asthma: Pooled Results from the PATHWAY and NAVIGATOR Studies.
Ian D Pavord, Christopher E Brightling, Stephanie Korn, Nicole L Martin, Sandhia S Ponnarambil

Pulm Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stop the Asthma Treatment Elevator, We Need to Get Off!
Andrew Bush, Ian D Pavord

Am J Respir Crit Care Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype.
Frank C Sciurba, Gerard J Criner, Stephanie A Christenson, Fernando J Martinez, Alberto Papi, Ian D Pavord

N Engl J Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response.
Simon Couillard, David J Jackson, Ian D Pavord, Michael E Wechsler

Chest· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug evaluation: mepolizumab in chronic obstructive pulmonary disease.
Matheus Rabahi, Ian D Pavord

Immunotherapy· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cough Reflex Hypersensitivity: A Common and Important Treatable Trait.
Ian D Pavord, Peter G Gibson

J Allergy Clin Immunol Pract· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial.
Dave Singh, Christopher E Brightling, Klaus F Rabe, MeiLan K Han, Stephanie A Christenson, Ian D Pavord

Lancet Respir Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of azithromycin in severe eosinophilic asthma with concomitant monoclonal antibody treatment.
Gabriel Lavoie, Imran Howell, James Melhorn, Catherine Borg, Laura Bermejo-Sanchez, Ian D Pavord

Thorax· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The epithelial era of asthma research: knowledge gaps and future direction for patient care.
Christopher E Brightling, Gianni Marone, Helena Aegerter, Pascal Chanez, Enrico Heffler, Ian D Pavord

Eur Respir Rev· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis